Grifols, S.A. Operating Expenses 2011-2026 | GRFS

Annual Operating Expenses Grifols, S.A.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.64 B	1.77 B	1.56 B	1.42 B	1.28 B	1.22 B	1.06 B	1.15 B	973 M	961 M	842 M	682 M	670 M	1.05 B

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
1.77 B	670 M	1.16 B

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
AbCellera Biologics ABCL	292 M	$ 3.44	-4.32 %	$ 1.03 B	Canada
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Aptorum Group Limited APM	20.7 M	$ 0.79	-1.15 %	$ 4.31 M	China
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
ADMA Biologics ADMA	101 M	$ 15.36	-2.17 %	$ 3.66 B	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Apellis Pharmaceuticals APLS	948 M	$ 20.28	0.65 %	$ 2.56 B	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.51	1.35 %	$ 385 M	Britain
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Anika Therapeutics ANIK	51.6 M	$ 14.05	-1.44 %	$ 206 M	USA
ANI Pharmaceuticals ANIP	127 M	$ 74.36	-1.64 %	$ 1.44 B	USA
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
AVEO Pharmaceuticals AVEO	44.9 M	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	99.1 M	$ 162.43	0.6 %	$ 8.08 B	USA
BioCryst Pharmaceuticals BCRX	144 M	$ 8.49	-0.18 %	$ 1.75 B	USA
BridgeBio Pharma BBIO	304 M	$ 65.66	-0.78 %	$ 12.6 B	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Bellerophon Therapeutics BLPH	22.4 M	-	-74.18 %	$ 955 K	USA
Bellicum Pharmaceuticals BLCM	28.5 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
BioLineRx Ltd. BLRX	28.1 M	$ 2.69	-0.74 %	$ 908 M	Israel
BioMarin Pharmaceutical BMRN	1.47 B	$ 61.3	1.21 %	$ 11.8 B	USA
Burford Capital Limited BUR	106 M	$ 7.79	-5.75 %	$ 1.28 B	Britain
CymaBay Therapeutics CBAY	133 M	-	-	$ 3.45 B	USA
Codexis CDXS	31.5 M	$ 1.23	-2.38 %	$ 90.3 M	USA
Cabaletta Bio CABA	74.7 M	$ 3.18	-0.16 %	$ 3.71 M	USA
Checkpoint Therapeutics CKPT	56.2 M	-	-	$ 169 M	USA
Clovis Oncology CLVS	425 M	-	-7.23 %	$ 13 M	USA